Cargando…
Existing and emerging therapies for the treatment of familial hypercholesterolemia
Familial hypercholesterolemia (FH), an autosomal dominant disorder of LDL metabolism that is characterized by elevated LDL-cholesterol, is commonly encountered in patients with atherosclerotic coronary heart disease. Combinations of cholesterol-lowering therapies are often used to lower LDL-choleste...
Autor principal: | Rosenson, Robert S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065289/ https://www.ncbi.nlm.nih.gov/pubmed/33716107 http://dx.doi.org/10.1016/j.jlr.2021.100060 |
Ejemplares similares
-
Lipoprotein metabolism in familial hypercholesterolemia
por: Chemello, Kévin, et al.
Publicado: (2021) -
Genetic testing for familial hypercholesterolemia—past, present, and future
por: Futema, Marta, et al.
Publicado: (2021) -
The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer
por: Seidah, Nabil G.
Publicado: (2021) -
The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation
por: Bernstein, Paul S., et al.
Publicado: (2021) -
Different disease, same challenges: Social determinants of tuberculosis and COVID-19
por: Duarte, R., et al.
Publicado: (2021)